AzTrials
AzTrials

Caesarean Scar NicheNCT06695793

Niche Investigated: Closure of Hysterotomy & Evaluation of 3 Suturing Techniques (Running, Interrupted, and Locked)

A study testing Interrupted Sutures, Locked Sutures and Running Continuous Sutures in people with Caesarean Scar Niche, run by Cairo University at 5 sites in Egypt.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This study aims to explore the impact of three different suturing techniques (Running, Interrupted \& Locked) that used to close the uterine incision at the cesarean section on the formation of a cesarean scar niche Read more about this study

Who is it for?
Ages 18 to 35 years, women onlyHealthy volunteers can take part
Conditions the study is for
Caesarean Scar Niche
What is being tested?
Interrupted Sutures, Locked Sutures and Running Continuous Sutures
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
225 participants
Where
5 sitesEgypt
Study dates
1 Nov 2024to 1 Nov 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 35 years
  • Women only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Women with a singleton pregnancy scheduled for elective cesarean section
  • Gestational age at the time of cesarean section between 38 and 40 weeks.
  • Willingness to participate in the study and provide informed consent
  • Age between 18 and 35 years old.
  • BMI <30

Who cannot join

  • Known uterine anomalies or previous uterine surgery (e.g, myomectomy, uterine septum resection)
  • Pre-existing medical conditions contraindicating cesarean delivery or affecting uterine healing (e.g., Anemia, Diabetes)
  • Current smokers.
  • Non-cephalic presentation of the fetus.
  • Low-lying anterior wall placenta and placenta previa.
  • Inability to provide informed consent (e.g., cognitive impairment, language barrier)
  • Any condition deemed by the attending physician to pose a risk to the participant or compromise the study's integrity, for example, Patients who will require excessive suturing for further hemostasis or those who require ligation of one or both uterine arteries

Trial locations and contacts

5 sites in 1 country. Contact the study team or a site near you to ask about taking part.

5 sites in 1 country

Egypt5 sites, 5 recruiting
  • Cairo University

    Cairo

    amr essam, +201004365349, amro_394@hotmail.com

    Recruiting
  • Cairo University

    Cairo

    Abdalla Mousa, +201277664430, Dr_abdallamousa@yahoo.com

    Recruiting
  • Cairo University

    Cairo

    Moutaz ElSherbiny, +20100158300, mizoelsherbini@yahoo.com

    Recruiting
  • Cairo University

    Cairo

    Mahmoud Soliman, +201222251268, dr_mahmoudsoliman@yahoo.com

    Recruiting
  • Cairo University

    Cairo

    Ibrahim Fawzy, +201062641235, ibrahimfawzyibrahimfawzy@gmail.com

    Recruiting

Other trials in Egypt

About this study

This study aims to explore the impact of three different suturing techniques (Running, Interrupted \& Locked) that used to close the uterine incision at the cesarean section on the formation of a cesarean scar niche

Being tested
Interrupted Sutures, Locked Sutures, Running Continuous Sutures

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Interrupted SuturesProcedure or surgery

    The first layer of uterine incision will be closed using individual, separate sutures placed at regular intervals along the incision line. Each suture will be tied independently, ensuring adequate apposition of uterine tissue, followed by a second layer of running continuous sutures.

  • Locked SuturesProcedure or surgery

    The first layer of uterine incision will be closed using continuous sutures placed along the uterine incision, incorporating a locking technique at specified intervals to prevent unraveling. The knots will be securely tied to maintain tissue approximation, followed by a second layer of running continuous sutures.

  • Running Continuous SuturesBiological

    Double layer closure of uterine incision using running continuous suture used to close the uterine incision without interruption, providing seamless tissue approximation throughout the incision length.

Study groups in NCT06695793
Study groupRoleWhat they receive
Group (A)ExperimentalInterrupted Sutures: The first layer of the uterine incision will be closed using individual, separate sutures placed at regular intervals along the incision line. Each suture will be tied independently, ensuring adequate apposition of uterine tissue, followed by a second layer of running continuous sutures.
Receives: Procedure: Interrupted Sutures
Group (B)ExperimentalLocked Sutures: The first layer of the uterine incision will be closed using continuous sutures placed along the uterine incision, incorporating a locking technique at specified intervals to prevent unraveling. The knots will be securely tied to maintain tissue approximation, followed by a second layer of running continuous sutures.
Receives: Procedure: Locked Sutures
Group (C)ExperimentalRunning Continuous Sutures: Double layer closure of uterine incision using running continuous suture used to close the uterine incision without interruption, providing seamless tissue approximation throughout the incision length.
Receives: Biological: Running Continuous Sutures

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Presence of caesarean scar niche and its dimensions.

    Follow-up visits will be scheduled at 6-12 weeks post-cesarean section to assess caesarean section niche formation using trans-vaginal ultrasound using Samsung Elite with endovaginal probe of frequency 6 - 12 MHz. Trained sonographers, blinded to the participants' suturing group, will perform the ultrasound examinations to evaluate caesarean section niche presence and its dimensions.

    Measured: 6-12 weeks post-cesarean section

Secondary outcomes (2)
  1. Operative time

    Measured: during operation

  2. Estimate blood loss

    Measured: during operation

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Nov 2024
  2. Study start1 Nov 2024
  3. Primary completion1 May 2026 (estimated)
  4. Study completion1 Nov 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Investigator
Enrolment
225 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06695793
Sponsor's protocol ID
MD-308-2024
Status last verified
Nov 2024
First submitted
17 Nov 2024
Last updated
19 Nov 2024
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Interrupted Sutures, Locked Sutures and Running Continuous Sutures in people with Caesarean Scar Niche, run by Cairo University at 5 sites in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 19 Nov 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 5 sites in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Abdalla Moussa (+20127664430, Dr_abdallamousa@yahoo.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Presence of caesarean scar niche and its dimensions. (time frame: 6-12 weeks post-cesarean section). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Nov 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in